Outcomes of Infliximab-Treated inflammatory bowel disease patients undergoing therapeutic drug monitoring with two different assays-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes of Infliximab-Treated inflammatory bowel disease patients undergoing therapeutic drug monitoring with two different assays

Published:2023-09 Issue: Volume:119 Page:110618
ISSN:0009-9120
Container-title:Clinical Biochemistry
language:en
Short-container-title:Clinical Biochemistry

Author:

Al-Bawardy Badr,Jenkins Sarah M.,Snyder Melissa R.^ORCID,Frinack Jody L.^ORCID,Ladwig Paula M.^ORCID,Loftus Edward V.^ORCID,Willrich Maria Alice V.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,General Medicine

Reference24 articles.

1. Loss of Response to Anti-TNFs: Definition, Epidemiology, and Management;Roda;Clin Transl Gastroenterol,2016

2. Systematic review: predicting and optimising response to anti-TNF therapy in Crohn's disease - algorithm for practical management;Ding;Aliment Pharmacol Ther,2016

3. Predictors of anti-TNF treatment failure in anti-TNF-naive patients with active luminal Crohn's disease: a prospective, multicentre, cohort study;Kennedy;Lancet Gastroenterol Hepatol,2019

4. Optimizing Anti-TNF-alpha Therapy: Serum Levels of Infliximab and Adalimumab Are Associated With Mucosal Healing in Patients With Inflammatory Bowel Diseases;Ungar;Clin Gastroenterol Hepatol,2016

5. Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis;Yarur;Inflamm Bowel Dis,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP